“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
Some Bankrupt Oil and Gas Drillers Can't Give Their Assets Away
How the NSA Halted My Rise as a Vermont Drug Lord
Commodities: High metal prices can put lives in danger
Homeland Security fights child pornography with new iPhone app
Afghan president: U.S. special forces creating ‘insecurity and instability’
India Wants To Kick Out A US Diplomat From Delhi In Retaliation
How CEOs are clueless about technology
Scots cafe becomes first to accept online currency Bitcoin as payment
New Zealand military told to soften manual that equates media with extremist groups
Feds secretly rolling out real estate cash reporting rules to more states
Germany will resume spying on U.S. for first time since 1945
NYPD urging people to upgrade Apple devices to iOS7 because it is 'safer'
FBI knew earlier of Boston bombing suspect Tsarnaev
Computer Glitch Blamed For Nationwide Food Stamp System Shutdown
Governments threatening teens for cutting grass without a business license